Trucheck™ Intelli is a non-invasive blood test designed to screen for circulating tumour cells (CTCs) and tumour-associated cellular clusters linked to a wide range of solid malignancies. The test uses immunocytochemistry-based detection methods to identify abnormal cell populations that may be present in peripheral blood before clinical symptoms develop.
Detection of CTCs may indicate potential tumour activity and support earlier clinical investigation. The test is intended as a screening tool rather than a diagnostic method and positive findings require follow-up with conventional imaging, laboratory testing or specialist assessment.
Results are interpreted alongside clinical history, age-related risk factors, family history and other screening outcomes. Integrating this information may help guide decisions around monitoring intervals, referral pathways and broader preventive health strategies.